Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions

Researchers in the Department of Emergency Medicine at UCLA David Geffen School of Medicine (Los Angeles, CA, USA) conducted a retrospective analysis of over 200,000 adult ED visits with CBC results between the period March 2013 and February 2022. The study’s key objective was to investigate the correlation between initial RDW measurements obtained during ED visits and two crucial outcomes: hospital admission and in-hospital mortality. The study revealed that elevated RDW levels were notably prevalent in visits culminating in hospital admission. Moreover, among admitted patients, those necessitating intensive care unit (ICU) care or experiencing in-hospital mortality exhibited even higher RDW values.

An RDW value of more than 16 demonstrated a specificity of 90% for predicting hospital admission, while an RDW value exceeding 18.5 demonstrated 90% specificity for predicting in-hospital mortality. These findings are in line with prior studies that have linked heightened RDW levels to higher mortality risks in conditions such as myocardial infarction, pulmonary embolism, heart failure, sepsis, and COVID-19. However, the latest study establishes a relation between RDW and overall hospital admissions as well as in-hospital mortality across all-cause adult ED visits. According to the researchers, while elevated RDW alone might not possess the sensitivity required for a comprehensive diagnostic tool, combining it with other clinical data could substantially enhance clinicians' capacity to predict hospital admissions and identify patients at heightened risk of in-hospital mortality.

Related Links:
UCLA David Geffen School of Medicine